fMet-Leu-Phe
别名 | fMetLeuPhe, formyl-Met-Leu-Phe |
---|---|
Compound Class | Peptide |
变动原因 | From the bacterium E.coli |
Related Product | N-甲酰-L-甲硫氨酰-L-白氨酰-L苯丙氨酸 |
Summary
是否批准为药物? | |
---|---|
IUPAC Name | (2S)-2-[[(2S)-2-[[(2S)-2-formamido-4-methylsulfanylbutanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoic acid |
别名 | fMetLeuPhe, formyl-Met-Leu-Phe |
数据库链接
PubChem CID | 443295 |
---|---|
Wikipedia | Chemotactic peptide, N-Formylmethionine-leucyl-phenylalanine |
ChEMBL Ligand | CHEMBL267179 |
GPCRdb Ligand | 1022 |
生物活性
临床资料
作用机制与药效学效应 |
Sulfonamides are structural analogues of 4-aminobenzoic acid (pABA) an intermediate in the de novo synthesis of folate by some prokaryotes, lower eukaryotes and plants |
---|
结构
Canonical SMILES | CSCCC(C(=O)NC(C(=O)NC(C(=O)O)Cc1ccccc1)CC(C)C)NC=O |
---|---|
Isomeric SMILES | CSCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1ccccc1)CC(C)C)NC=O |
InChI | InChI=1S/C21H31N3O5S/c1-14(2)11-17(23-19(26)16(22-13-25)9-10-30-3)20(27)24-18(21(28)29)12-15-7-5-4-6-8-15/h4-8,13-14,16-18H,9-12H2,1-3H3,(H,22,25)(H,23,26)(H,24,27)(H,28,29)/t16-,17-,18-/m0/s1 |
InChI key | PRQROPMIIGLWRP-BZSNNMDCSA-N |
Peptide Sequence | MLP |
Chemical Modification | N-terminal residue is formyl-methionine |